Leucine-Rich alpha-2 Glycoprotein 1 (LRG1) (N-Term) Peptid
LRG1
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN979557
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für Leucine-Rich alpha-2 Glycoprotein 1 (LRG1) (N-Term) Peptid (ABIN979557)
Target
LRG1
(Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- GVTLSPKDCQ VFRSDHGSSI SCQPPAEIPG YLPADTVHLA VEFFNLTHLP
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LRG1 Antibody(ARP52475_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LRG1 (Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))
-
Hintergrund
-
The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation (O'Donnell et al., 2002 [PubMed 12223515]).
Alias Symbols: HMFT1766, LRG
Protein Interaction Partner: FN1
Protein Size: 347 -
Molekulargewicht
- 38 kDa
-
Gen-ID
- 116844
-
NCBI Accession
- NM_052972, NP_443204
-
UniProt
- P02750
Target
-
Sie sind hier:
